Cytomed Therapeutics Limited Stock Price on October 6, 2023
| GDTC Stock | 2.29 0.67 22.64% |
If you're considering investing in CytoMed Stock, it is important to understand the factors that can impact its price. As of today, the current price of CytoMed Therapeutics stands at 2.29, as last reported on the 9th of January, with the highest price reaching 2.85 and the lowest price hitting 2.29 during the day. CytoMed Therapeutics appears to be dangerous, given 3 months investment horizon. CytoMed Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0618, which signifies that the company had a 0.0618% return per unit of risk over the last 3 months. By analyzing CytoMed Therapeutics' technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of CytoMed Therapeutics' Downside Deviation of 6.01, mean deviation of 5.35, and Risk Adjusted Performance of 0.1207 to double-check if our risk estimates are consistent with your expectations.
At present, CytoMed Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 21.7 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 8.1 M. . At present, CytoMed Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 316.54, whereas Price Earnings Ratio is forecasted to decline to (15.72). CytoMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CytoMed |
Sharpe Ratio = 0.0618
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GDTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.29 actual daily | 73 73% of assets are less volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average CytoMed Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CytoMed Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.5844 | Enterprise Value Ebitda (4.45) | Price Sales 76.2984 | Shares Float 3.5 M | Wall Street Target Price 5 |
CytoMed Therapeutics Valuation on October 6, 2023
It is possible to determine the worth of CytoMed Therapeutics on a given historical date. On October 6, 2023 CytoMed was worth 3.48 at the beginning of the trading date compared to the closed value of 3.48. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CytoMed Therapeutics stock. Still, in general, we apply an absolute valuation method to find CytoMed Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CytoMed Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CytoMed Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.48 | 3.65 | 3.48 | 3.64 | 3,400 | |
10/06/2023 | 3.48 | 3.50 | 3.47 | 3.48 | 7,000 |
| 3.28 | 3.41 | 3.28 | 3.40 | 2,900 |
| Backtest CytoMed Therapeutics | | | CytoMed Therapeutics History | | | CytoMed Therapeutics Valuation | Previous | Next |
CytoMed Therapeutics Trading Date Momentum on October 6, 2023
| On October 09 2023 CytoMed Therapeutics Limited was traded for 3.40 at the closing time. The top price for the day was 3.41 and the lowest listed price was 3.28 . The trading volume for the day was 2.9 K. The trading history from October 9, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.30% . The overall trading delta against the current closing price is 3.74% . |
CytoMed Therapeutics Fundamentals Correlations and Trends
By evaluating CytoMed Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CytoMed Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CytoMed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CytoMed Therapeutics Stock history
CytoMed Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CytoMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CytoMed Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CytoMed Therapeutics stock prices may prove useful in developing a viable investing in CytoMed Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.2 M | 8.1 M | |
| Net Loss | -2.8 M | -3 M |
CytoMed Therapeutics Stock Technical Analysis
CytoMed Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CytoMed Therapeutics Period Price Range
Low | January 9, 2025
| High |
0.00 | 0.00 |
CytoMed Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CytoMed Therapeutics January 9, 2025 Market Strength
Market strength indicators help investors to evaluate how CytoMed Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CytoMed Therapeutics shares will generate the highest return on investment. By undertsting and applying CytoMed Therapeutics stock market strength indicators, traders can identify CytoMed Therapeutics Limited entry and exit signals to maximize returns
CytoMed Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CytoMed Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CytoMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CytoMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1207 | |||
| Jensen Alpha | 1.04 | |||
| Total Risk Alpha | 1.05 | |||
| Sortino Ratio | 0.1736 | |||
| Treynor Ratio | (13.34) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CytoMed Stock analysis
When running CytoMed Therapeutics' price analysis, check to measure CytoMed Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytoMed Therapeutics is operating at the current time. Most of CytoMed Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytoMed Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytoMed Therapeutics' price. Additionally, you may evaluate how the addition of CytoMed Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |